These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20543203)

  • 21. Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia.
    Bunda S; Kang MW; Sybingco SS; Weng J; Favre H; Shin DH; Irwin MS; Loh ML; Ohh M
    Cancer Res; 2013 Apr; 73(8):2540-50. PubMed ID: 23400592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The International Consensus Classification (ICC) of hematologic neoplasms with germline predisposition, pediatric myelodysplastic syndrome, and juvenile myelomonocytic leukemia.
    Rudelius M; Weinberg OK; Niemeyer CM; Shimamura A; Calvo KR
    Virchows Arch; 2023 Jan; 482(1):113-130. PubMed ID: 36445482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Juvenile myelomonocytic leukemia: who's the driver at the wheel?
    Niemeyer CM; Flotho C
    Blood; 2019 Mar; 133(10):1060-1070. PubMed ID: 30670449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Juvenile myelomonocytic leukaemia and Noonan syndrome.
    Strullu M; Caye A; Lachenaud J; Cassinat B; Gazal S; Fenneteau O; Pouvreau N; Pereira S; Baumann C; Contet A; Sirvent N; Méchinaud F; Guellec I; Adjaoud D; Paillard C; Alberti C; Zenker M; Chomienne C; Bertrand Y; Baruchel A; Verloes A; Cavé H
    J Med Genet; 2014 Oct; 51(10):689-97. PubMed ID: 25097206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy.
    Guey S; Grangeon L; Brunelle F; Bergametti F; Amiel J; Lyonnet S; Delaforge A; Arnould M; Desnous B; Bellesme C; Hervé D; Schwitalla JC; Kraemer M; Tournier-Lasserve E; Kossorotoff M
    J Med Genet; 2017 Aug; 54(8):550-557. PubMed ID: 28343148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia.
    Park HD; Lee SH; Sung KW; Koo HH; Jung NG; Cho B; Kim HK; Park IA; Lee KO; Ki CS; Kim SH; Yoo KH; Kim HJ
    Ann Hematol; 2012 Apr; 91(4):511-7. PubMed ID: 21901340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome.
    Lasho T; Patnaik MM
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101171. PubMed ID: 32460983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Diversity and Associated Phenotypic Spectrum of Germline CBL Mutations.
    Martinelli S; Stellacci E; Pannone L; D'Agostino D; Consoli F; Lissewski C; Silvano M; Cencelli G; Lepri F; Maitz S; Pauli S; Rauch A; Zampino G; Selicorni A; Melançon S; Digilio MC; Gelb BD; De Luca A; Dallapiccola B; Zenker M; Tartaglia M
    Hum Mutat; 2015 Aug; 36(8):787-96. PubMed ID: 25952305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome.
    Shiba N; Kato M; Park MJ; Sanada M; Ito E; Fukushima K; Sako M; Arakawa H; Ogawa S; Hayashi Y
    Leukemia; 2010 May; 24(5):1090-2. PubMed ID: 20357823
    [No Abstract]   [Full Text] [Related]  

  • 30. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL.
    Gagne AL; Maguire JA; Gandre-Babbe S; Chou ST; Tasian SK; Loh ML; Weiss MJ; Gadue P; French DL
    Stem Cell Res; 2018 Aug; 31():157-160. PubMed ID: 30096712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.
    Makishima H; Cazzolli H; Szpurka H; Dunbar A; Tiu R; Huh J; Muramatsu H; O'Keefe C; Hsi E; Paquette RL; Kojima S; List AF; Sekeres MA; McDevitt MA; Maciejewski JP
    J Clin Oncol; 2009 Dec; 27(36):6109-16. PubMed ID: 19901108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term remission of infantile Takayasu arteritis associated with germline CBL syndrome after allogeneic hematopoietic stem cell transplantation: A case report and literature review.
    Munoz-Osores E; Piñones M; Barriga F; Wietstruck MA; Pérez-Mateluna G; Mellado C; Aracena M; Parra R; García C; Borzutzky A
    Transpl Immunol; 2024 Apr; 83():102013. PubMed ID: 38395087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelodysplastic and myeloproliferative disorders of childhood.
    Hasle H
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):598-604. PubMed ID: 27913534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germ-line mutation of the NRAS gene may be responsible for the development of juvenile myelomonocytic leukaemia.
    De Filippi P; Zecca M; Lisini D; Rosti V; Cagioni C; Carlo-Stella C; Radi O; Veggiotti P; Mastronuzzi A; Acquaviva A; D'Ambrosio A; Locatelli F; Danesino C
    Br J Haematol; 2009 Dec; 147(5):706-9. PubMed ID: 19775298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent somatic KRAS mutation and germline 10q22.3-q23.2 deletion in a patient with juvenile myelomonocytic leukemia, developmental delay, and multiple malformations: a case report.
    Yao R; Yu T; Xu Y; Li G; Yin L; Zhou Y; Wang J; Yan Z
    BMC Med Genomics; 2018 Jul; 11(1):60. PubMed ID: 30012129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline bi-allelic
    Arfeuille C; Vial Y; Cadenet M; Caye-Eude A; Fenneteau O; Neven Q; Bonnard AA; Pizzi S; Carpentieri G; Capri Y; Girardi K; Pedace L; Macchiaiolo M; Boudhar K; Khaled MB; Chahla WA; Lutun A; Fahd M; Drunat S; Flex E; Dalle JH; Strullu M; Locatelli F; Tartaglia M; Cavé H
    Haematologica; 2024 Aug; 109(8):2542-2554. PubMed ID: 37981895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological and hematological findings as major features in a patient with a new germline pathogenic CBL variant.
    Stellacci E; Carter JN; Pannone L; Stevenson D; Moslehi D; Venanzi S; ; Bernstein JA; Tartaglia M; Martinelli S
    Am J Med Genet A; 2024 Aug; 194(8):e63627. PubMed ID: 38613168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.
    Sugimoto Y; Muramatsu H; Makishima H; Prince C; Jankowska AM; Yoshida N; Xu Y; Nishio N; Hama A; Yagasaki H; Takahashi Y; Kato K; Manabe A; Kojima S; Maciejewski JP
    Br J Haematol; 2010 Jul; 150(1):83-7. PubMed ID: 20408841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of acute lymphoblastic leukemia and juvenile myelomonocytic leukemia in a patient with Noonan syndrome carrying the germline PTPN11 mutation p.E139D.
    Pauli S; Steinemann D; Dittmann K; Wienands J; Shoukier M; Möschner M; Burfeind P; Manukjan G; Göhring G; Escherich G
    Am J Med Genet A; 2012 Mar; 158A(3):652-8. PubMed ID: 22315187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience.
    Hamdy N; Bokhary H; Elsayed A; Hozayn W; Soliman S; Salem S; Alsheshtawi K; Abdalla A; Hafez H; Hammad M
    Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e368-e374. PubMed ID: 32209330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.